Paclitaxel Induces Epidermal Molecular Changes and Produces Subclinical Alterations in the Skin of Gynecological Cancer Patients.

Paula MonteroMartín Pérez-LealJose Alejandro Pérez-FidalgoCelia SanzCristina EstornutInés RogerJavier MilaraAndres CervantesJulio Cortijo

Published in: Cancers (2022)

Results suggest that paclitaxel modifies gene and protein expression of skin-related molecular markers, and impairs different physical, physiological, and biomechanical properties of the skin of cancer patients at a subclinical level.

Keyphrases

wound healing
soft tissue
physical activity
mental health
drug induced